Keyphrases
Adolescent Patients
100%
Acute Liver Injury
100%
Acute Kidney Injury
100%
Obese Adolescents
100%
Liraglutide
100%
Weight Loss
25%
Receptor Agonist
25%
A1 Receptor
25%
Glucagon-like
25%
Hepatic Injury
25%
Treatment Duration
12%
U.S. Food
12%
Physical Activity
12%
Adverse Effects
12%
Ultra-low Dose
12%
Obesity
12%
Young Males
12%
Adverse Drug Reaction
12%
Second-line Therapy
12%
Adjunctive Therapy
12%
Pharmacotherapy
12%
Liver Enzymes
12%
Significant Loss
12%
Probability Scale
12%
Weight Management
12%
Reduced Fat
12%
Normal Kidney
12%
Obesity Management
12%
Melancholy
12%
Appetite Loss
12%
American Academy of Pediatrics Guidelines
12%
Class III Obesity
12%
Potential Adverse Effects
12%
Hepatic Transaminases
12%
Reaction Probability
12%
Medicine and Dentistry
Low Drug Dose
100%
Liver Injury
100%
Acute Kidney Injury
100%
Liraglutide
100%
Adolescence
100%
Adverse Event
25%
Glucagon-Like Peptide-1 Agonist
25%
Pediatrics
12%
Drug Therapy
12%
Adjuvant Therapy
12%
Physical Activity
12%
Liver Enzyme
12%
Adverse Drug Reaction
12%
Alertness
12%
Weight Management
12%
Transaminase
12%
Loss of Appetite
12%
Melancholia
12%
Obesity Management
12%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Injury
100%
Acute Kidney Failure
100%
Liraglutide
100%
Adverse Event
25%
Glucagon Like Peptide 1 Receptor Agonist
25%
Pharmacotherapy
12%
Adverse Drug Reaction
12%
Liver Enzyme
12%
Aminotransferase
12%
Loss of Appetite
12%
Melancholia
12%